share_log

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4:持股變動聲明-股東 Nirland Ltd
美股SEC公告 ·  10/03 05:05

牛牛AI助理已提取核心訊息

Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland有限公司,Conduit Pharmaceuticals(CDt.US)的股東,已從2024年9月30日至2024年10月2日進行了一系列股票處置。這些交易涉及以每股價格在0.1028美元至0.12美元之間出售總共260萬股普通股。處置股份的總市值約爲297,644.36美元。在這些交易之後,Nirland有限公司在Conduit Pharmaceuticals的直接持股減少至990萬股。這些銷售是作爲公開市場或私人銷售執行的,並且目前仍在進行中。
Nirland有限公司,Conduit Pharmaceuticals(CDt.US)的股東,已從2024年9月30日至2024年10月2日進行了一系列股票處置。這些交易涉及以每股價格在0.1028美元至0.12美元之間出售總共260萬股普通股。處置股份的總市值約爲297,644.36美元。在這些交易之後,Nirland有限公司在Conduit Pharmaceuticals的直接持股減少至990萬股。這些銷售是作爲公開市場或私人銷售執行的,並且目前仍在進行中。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。